These Adverse Events Linked to Improved Cancer Prognosis
Cutaneous immune-related adverse events are associated with a better prognosis among patients with cancer who receive immune checkpoint inhibitors, new research suggests.
Medscape Medical News
source https://www.medscape.com/viewarticle/996902?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/996902?src=rss
Comments
Post a Comment